Instrumento Inactivo

Acciones Human Genome Sciences

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	03/08/12
Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	26/07/12
Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	26/07/12
Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	20/07/12
Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	18/07/12

Sector

	Varia. 1 de ene.	Capi.
IQVIA HOLDINGS INC.	+1,51 %	42,75 mil M
LONZA GROUP AG	+49,22 %	41,61 mil M
MODERNA, INC.	+8,57 %	41,34 mil M
CELLTRION, INC.	-12,36 %	26,59 mil M
ICON PUBLIC LIMITED COMPANY	+8,92 %	25,49 mil M
ALNYLAM PHARMACEUTICALS, INC.	-25,13 %	18,12 mil M
MEDPACE HOLDINGS, INC.	+29,17 %	12,24 mil M
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12 %	11,76 mil M
UNITED THERAPEUTICS CORPORATION	+6,35 %	11 mil M